Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hypertension

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    November 2019
  1. IVES CW, Oparil S
    What is the first choice for blood pressure treatment?
    Lancet. 2019;394:1782-1784.
    PubMed     Text format    


    October 2019
  2. GANESAN C, Pao AC
    Spironolactone plus patiromer: proceed with caution.
    Lancet. 2019;394:1486-1488.
    PubMed     Text format    


  3. THE LANCET
    Where next for randomised controlled trials in global health?
    Lancet. 2019;394:1481.
    PubMed     Text format    


  4. SUCHARD MA, Schuemie MJ, Krumholz HM, You SC, et al
    Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Lancet. 2019 Oct 24. pii: S0140-6736(19)32317.
    PubMed     Text format     Abstract available


    September 2019
  5. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    PubMed     Text format     Abstract available


  6. AGARWAL R, Rossignol P, Romero A, Garza D, et al
    Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2019 Sep 13. pii: S0140-6736(19)32135.
    PubMed     Text format     Abstract available


  7. THE LANCET
    NICE hypertension guidelines: a pragmatic compromise.
    Lancet. 2019;394:806.
    PubMed     Text format    


    August 2019
  8. SCHWALM JD, McCready T, Lopez-Jaramillo P, Yusoff K, et al
    A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31949.
    PubMed     Text format     Abstract available


  9. JAFAR TH, Samad Z, Bloomfield GS
    Parallel community solutions for cardiovascular risk reduction.
    Lancet. 2019 Aug 30. pii: S0140-6736(19)31995.
    PubMed     Text format    


  10. THE LANCET
    Is the concept of hypertension as a disease unhelpful?
    Lancet. 2019;394:611.
    PubMed     Text format    


  11. CHOW CK, Gupta R
    Blood pressure control: a challenge to global health systems.
    Lancet. 2019;394:613-615.
    PubMed     Text format    


  12. LEMOINE ER, Karumanchi SA
    Oral regimen management of acute hypertension in pregnancy.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31717.
    PubMed     Text format    


  13. EASTERLING T, Mundle S, Bracken H, Parvekar S, et al
    Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet. 2019 Aug 1. pii: S0140-6736(19)31282.
    PubMed     Text format     Abstract available


    July 2019
  14. KAHAN T
    Strategies to identify patients for antihypertensive treatment.
    Lancet. 2019 Jul 25. pii: S0140-6736(19)31665.
    PubMed     Text format    


  15. HERRETT E, Gadd S, Jackson R, Bhaskaran K, et al
    Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study.
    Lancet. 2019 Jul 25. pii: S0140-6736(19)31359.
    PubMed     Text format     Abstract available


  16. GELDSETZER P, Manne-Goehler J, Marcus ME, Ebert C, et al
    The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1.1 million adults.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)30955.
    PubMed     Text format     Abstract available



  17. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)31145.
    PubMed     Text format     Abstract available


  18. BENJAMIN IJ, Kreutz R, Olsen MH, Schutte AE, et al
    Fixed-dose combination antihypertensive medications.
    Lancet. 2019 Jul 15. pii: S0140-6736(19)31629.
    PubMed     Text format    


    May 2019
  19. FUDIM M, Ali-Ahmed F, Patel MR, Sobotka PA, et al
    Sham trials: benefits and risks for cardiovascular research and patients.
    Lancet. 2019;393:2104-2106.
    PubMed     Text format    


    April 2019
  20. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
    Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
    PubMed     Text format     Abstract available


    March 2019
  21. MENTE A, O'Donnell MJ, Yusuf S
    Urinary sodium excretion measures and health outcomes - Authors' reply.
    Lancet. 2019;393:1295-1296.
    PubMed     Text format    


  22. VILLANUEVA C, Albillos A, Genesca J, Garcia-Pagan JC, et al
    beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)31875.
    PubMed     Text format     Abstract available


  23. GAZZARD G, Konstantakopoulou E, Garway-Heath D, Garg A, et al
    Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32213.
    PubMed     Text format     Abstract available


    February 2019

  24. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    Lancet. 2019 Feb 5. pii: S0140-6736(19)30194.
    PubMed     Text format     Abstract available


    December 2018
  25. YOUSEFIFARD M, Hosseini M
    Should the cutoff for hypertension in older adults be different from younger adults?
    Lancet. 2018;392:2438-2439.
    PubMed     Text format    


    November 2018
  26. OLIVA-DAMASO N, Costa-Fernandez J, Oliva-Damaso E, Bravo-Marques R, et al
    Kidneys are key in secondary hypertension: a case of fibromuscular dysplasia.
    Lancet. 2018;392:2298.
    PubMed     Text format    


    October 2018
  27. LU J, Lu Y, Krumholz HM, Jiang L, et al
    Prevalence and control of hypertension - Authors' reply.
    Lancet. 2018;392:1306.
    PubMed     Text format    


  28. BOVET P, Chiolero A
    Prevalence and control of hypertension.
    Lancet. 2018;392:1305-1306.
    PubMed     Text format    


  29. CORDONNIER C, Demchuk A, Ziai W, Anderson CS, et al
    Intracerebral haemorrhage: current approaches to acute management.
    Lancet. 2018;392:1257-1268.
    PubMed     Text format     Abstract available


    September 2018
  30. OPARIL S, Fu RH
    Revisiting ASCOT 16 years later.
    Lancet. 2018;392:1092-1094.
    PubMed     Text format    


  31. KISHORE SP, Salam A, Rodgers A, Jaffe MG, et al
    Fixed-dose combinations for hypertension.
    Lancet. 2018;392:819-820.
    PubMed     Text format    


    August 2018
  32. GUPTA A, Mackay J, Whitehouse A, Godec T, et al
    Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31776.
    PubMed     Text format     Abstract available


    July 2018
  33. HE FJ, Zhang P, Li Y, MacGregor GA, et al
    Action on Salt China.
    Lancet. 2018;392:7-9.
    PubMed     Text format    


    June 2018
  34. KJELDSEN SE, Esler MD
    Take a blood pressure pill or undergo renal denervation?
    Lancet. 2018;391:2298-2300.
    PubMed     Text format    


    May 2018
  35. BLANKESTIJN PJ, Bots ML
    Renal denervation in uncontrolled hypertension: the story continues to unfold.
    Lancet. 2018 May 22. pii: S0140-6736(18)31112.
    PubMed     Text format    


  36. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)31082.
    PubMed     Text format     Abstract available


  37. KANDZARI DE, Bohm M, Mahfoud F, Townsend RR, et al
    Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Lancet. 2018 May 22. pii: S0140-6736(18)30951.
    PubMed     Text format     Abstract available


    February 2018
  38. RIETZSCHEL ER, De Buyzere ML
    Hypertension: time for doctors to switch the driver's seat?
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30317.
    PubMed     Text format    


  39. MCMANUS RJ, Mant J, Franssen M, Nickless A, et al
    Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.
    Lancet. 2018 Feb 27. pii: S0140-6736(18)30309.
    PubMed     Text format     Abstract available


    January 2018
  40. CHAKER L, Bianco AC, Jonklaas J, Peeters RP, et al
    Hypothyroidism and hypertension: fact or myth? - Authors' reply.
    Lancet. 2018;391:30.
    PubMed     Text format    


  41. HOFSTETTER L, Messerli FH
    Hypothyroidism and hypertension: fact or myth?
    Lancet. 2018;391:29-30.
    PubMed     Text format    


    October 2017
  42. SU M, Zhang Q, Bai X, Wu C, et al
    Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32476.
    PubMed     Text format     Abstract available


  43. HESKETH T, Zhou X
    Hypertension in China: the gap between policy and practice.
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32743.
    PubMed     Text format    


  44. LU J, Lu Y, Wang X, Li X, et al
    Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lancet. 2017 Oct 25. pii: S0140-6736(17)32478.
    PubMed     Text format     Abstract available


    September 2017
  45. SPIERING W, Williams B, Van der Heyden J, van Kleef M, et al
    Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32337.
    PubMed     Text format     Abstract available


  46. COURAND PY, Lantelme P
    Stretching the carotid sinus to treat resistant hypertension.
    Lancet. 2017 Sep 1. pii: S0140-6736(17)32298.
    PubMed     Text format    


    August 2017
  47. AZIZI M
    Catheter-based renal denervation for treatment of hypertension.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32293.
    PubMed     Text format    


  48. TOWNSEND RR, Mahfoud F, Kandzari DE, Kario K, et al
    Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32281.
    PubMed     Text format     Abstract available


    July 2017
  49. RODGERS A, Chow CK, Thakkar J, Bennett A, et al
    A personalised or procrustean approach to treating hypertension? - Authors' reply.
    Lancet. 2017;390:27-28.
    PubMed     Text format    


  50. GABB GM, Mol PGM, Arnolda LF
    A personalised or procrustean approach to treating hypertension?
    Lancet. 2017;390:26-27.
    PubMed     Text format    


    June 2017
  51. MUNDLE S, Bracken H, Khedikar V, Mulik J, et al
    Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31367.
    PubMed     Text format     Abstract available


  52. SURI V, Sikka P
    Oral misoprostol for induction of labour in hypertensive pregnancies.
    Lancet. 2017 Jun 28. pii: S0140-6736(17)31453.
    PubMed     Text format    


    April 2017
  53. VIDAL-PETIOT E, Bhatt DL, Fox KM, Steg PG, et al
    Blood pressure and cardiovascular outcomes: a closer look - Authors' reply.
    Lancet. 2017;389:1296-1297.
    PubMed     Text format    


  54. WALD NJ, Wald DS
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1296.
    PubMed     Text format    


  55. DOUMAS M, Stavropoulos KV, Boutari C, Imprialos KP, et al
    Blood pressure and cardiovascular outcomes: a closer look.
    Lancet. 2017;389:1295-1296.
    PubMed     Text format    


    December 2016
  56. SLIWA K
    The heart of Africa: succeeding against the odds.
    Lancet. 2016;388:e28-e36.
    PubMed     Text format     Abstract available


    October 2016
  57. MENTE A, O'Donnell MJ, Yusuf S
    Sodium and cardiovascular disease - Authors' reply.
    Lancet. 2016;388:2113-2114.
    PubMed     Text format    


  58. CAPPUCCIO FP
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112.
    PubMed     Text format    


  59. KATZ J
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2112-2113.
    PubMed     Text format    


  60. STRAZZULLO P, Giampaoli S, Iacoviello L, Rossi L, et al
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111.
    PubMed     Text format    


  61. WALD N, Law M
    Sodium and cardiovascular disease.
    Lancet. 2016;388:2111-2112.
    PubMed     Text format    


  62. ALDERMAN MH
    Dietary sodium: paradigm shifts from public health to clinical medicine.
    Lancet. 2016;388:2110.
    PubMed     Text format    


    August 2016
  63. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: